Stock TT5 XTACY THERAPEUTICS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Xtacy Therapeutics Corp. Deutsche Boerse AG

Equities

TT5

CA98423G1072

Delayed Deutsche Boerse AG
Other stock markets
 07:07:10 30/05/2024 BST 		5-day change 1st Jan Change
0.011 EUR 0.00% Intraday chart for Xtacy Therapeutics Corp. -26.67% -12.00%
04-17 Xtacy Therapeutics Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
04-15 Xtacy Therapeutics Corp. Reports Earnings Results for the Full Year Ended September 30, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Investment Management & Fund Operators

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
BLACKROCK, INC. Stock BlackRock, Inc.
 112B
UBS GROUP AG Stock UBS Group AG
 98.02B -
BROOKFIELD CORPORATION Stock Brookfield Corporation
 65.15B - - - - -
APOLLO GLOBAL MANAGEMENT, INC. Stock Apollo Global Management, Inc.
 64.39B - -
BANK OF NEW YORK MELLON CORPORATION (THE) Stock Bank of New York Mellon Corporation (The)
 43.19B -
  1. Stock Market
  2. Equities
  3. XTCY Stock
  4. TT5 Stock
  5. Charts Xtacy Therapeutics Corp.
  6. Sector Chart